Chrono-behavioral Therapy for Chronic Fatigue in Cancer
Launched by AARHUS UNIVERSITY HOSPITAL · Feb 24, 2025
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new therapy called Chrono-behavioral Therapy (ChronoBT) designed to help cancer survivors dealing with chronic fatigue, which is a common and exhausting side effect after cancer treatment. The goal of this therapy is to improve daily habits related to light exposure, physical activity, and eating, all of which can help restore the body's natural 24-hour rhythms. Researchers believe that by strengthening these daily cues, they can significantly reduce fatigue and improve the quality of life for cancer survivors.
To participate in this trial, individuals must be survivors of prostate or breast cancer who finished their treatment at least a year ago. They should be at least 18 years old, able to read and speak Danish, and experiencing chronic fatigue. However, those who have used light therapy recently, have certain medical or psychiatric conditions, or are dealing with other factors that could cause fatigue may not be eligible. Participants can expect to engage in a home-based program that is designed to be easy to follow and manageable. This trial is currently not recruiting participants, but it aims to provide valuable insights into how to better support cancer survivors facing fatigue.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. prostate or female breast cancer survivors
- • 2. completed local and/or adjuvant cancer therapy (with the exception of hormonal therapy) ≥ 1 year previously
- • 3. ≥18 years of age
- • 4. able to speak and read Danish
- • 5. experiencing CRF (score ≤36 on FACT-F)
- Exclusion Criteria:
- • 1. use of light therapy in the last year
- • 2. confounding underlying medical/psychiatric disorders or use of medications associated with fatigue (e.g., a central nervous system cancer, untreated hypothyroidism, anemia, chronic fatigue syndrome, insomnia, major depression)
- • 3. non-cancer related factor likely to be a driver of fatigue (e.g., shift work, pregnancy, recent travel across time zones)
- • 4. recurrence of cancer or new cancer
- • 5. physical or psychological conditions that could prevent participation in intervention components
- • 6. use of photosensitizing medications
About Aarhus University Hospital
Aarhus University Hospital is a leading research institution in Denmark, dedicated to advancing medical science and improving patient care through innovative clinical trials. As a key sponsor of clinical research, the hospital integrates cutting-edge technology and multidisciplinary expertise to conduct studies that address critical health challenges. With a commitment to ethical standards and patient safety, Aarhus University Hospital collaborates with a diverse network of academic and industry partners, ensuring that its research initiatives contribute to the global body of medical knowledge and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aarhus, , Denmark
Patients applied
Trial Officials
Lisa M Wu, PhD
Principal Investigator
University of Aarhus
Ali Amidi, PhD
Principal Investigator
University of Aarhus
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported